OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit

Written By Michael Gary Scott







Outset Medical, Inc. Faces Securities Fraud Lawsuit

An Opportunity for OM Investors

LOS ANGELES, Sept. 6, 2024 — The Law Offices of Frank R. Cruz announces that investors with substantial losses have an opportunity to lead the securities fraud class action lawsuit against Outset Medical, Inc. (“Outset Medical” or the “Company”) with the ticker symbol OM.

Class Period: August 1, 2022August 7, 2024
Lead Plaintiff Deadline: October 28, 2024

If you are a shareholder who suffered a loss, click here to participate.

The complaint alleges that Defendants failed to disclose to investors key information, including an inappropriate marketing campaign for Tablo products and risks of ceasing sales due to pending FDA approval.

Join us on Twitter for updates: twitter.com/FRC_LAW.

To be part of the class action, you need not take immediate action; you may retain counsel of your choice or remain an absent member. For more information, contact Frank R. Cruz or visit their website.

This press release may be considered Attorney Advertising in some jurisdictions.

View original content to download multimedia:Original Content Link


See also  Unpacking Wall Street's Bullish Views on Alibaba (BABA)